Your browser doesn't support javascript.
loading
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.
Bengtson, Lindsay G S; Lutsey, Pamela L; Chen, Lin Y; MacLehose, Richard F; Alonso, Alvaro.
Afiliação
  • Bengtson LGS; Health Economics and Outcomes Research, Life Sciences, Optum, Eden Prairie, MN, USA. Electronic address: lindsay.bengtson@optum.com.
  • Lutsey PL; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Chen LY; Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
  • MacLehose RF; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Alonso A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: alvaro.alonso@emory.edu.
J Cardiol ; 69(6): 868-876, 2017 Jun.
Article em En | MEDLINE | ID: mdl-27889397

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Fibrilação Atrial / Varfarina / Rivaroxabana / Dabigatrana / Anticoagulantes Tipo de estudo: Prognostic_studies Idioma: En Revista: J Cardiol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Fibrilação Atrial / Varfarina / Rivaroxabana / Dabigatrana / Anticoagulantes Tipo de estudo: Prognostic_studies Idioma: En Revista: J Cardiol Ano de publicação: 2017 Tipo de documento: Article